Small, 3D-printed devices, designed to be implanted directly under the skin, could allow people with type 1 diabetes to ...

Humulin N isn’t a type of regular insulin. Regular insulins are typically short-acting insulins, which take about 30 minutes to start working after they’re injected.

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

A global research team, led by Wake Forest University’s Dr. Quentin Perrier, has successfully 3D-printed functioning human ...

Peptide inhibitors of insulin-regulated aminopeptidase (IRAP) enhance fear avoidance and spatial memory and accelerate spatial learning in a number of memory paradigms. Using a virtual screening ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...

Three highly stable, hexacoordinated nonoxidovanadium(IV), VIV(L)2, complexes (1–3) have been isolated and structurally characterized with tridentate aroylhydrazonates containing ONO donor atoms. All ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

The once-weekly insulin analog lowered A1c as effectively as once-daily formulations in three new trials in type 2 diabetes.

Summary: In the manuscript "Mapping HIV-1 RNA Structure, Homodimers, Long-Range Interactions and 1 persistent domains by HiCapR" Zhang et al report results from an omics-type approach to mapping RNA ...

Cost savings: Long-acting therapies may contribute to overall cost savings through improved adherence and reduced disease incidence, which in turn lowers long-term healthcare expenditures. Health ...